As of December 2024 Inhibrx has a market cap of A$0.35 Billion. This makes Inhibrx the world's 7978th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 30th, 2024 the market cap of Inhibrx was reported to be: